COMMUNIQUÉS West-GlobeNewswire

OKYO Pharma to Participate in 2026 Jefferies Global Healthcare Conference in London
12/11/2026
LONDON and NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
VETmAb Biosciences Appoints Katja Buhrer as Chief Operating Officer
12/11/2026
SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- VETmAb Biosciences (VETmAb BIO), a clinical-stage biopharmaceutical company developing transformative biologics for pets, today announced the appointment of Katja Buhrer as [...]
TScan Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
12/11/2026
Announced strategic reorganization to focus on in vivo-engineered TCR-T cell therapy for solid tumors Advancing PRAME- and MAGE-A4-targeted in vivo TCR-T candidates for solid tumors through IND-enabling studies; on [...]
Commit Biologics nominates first development candidate from BiCE™, its complement system engaging platform, and strengthens senior leadership
12/11/2026
COM002 is a first-in-class complement-powered immune engager based on Commit Biologics’ proprietary BiCE™ platform. Anne-Marie Levy Rasmussen appointed Chief Operating Officer and Dr. Benjamin Ole Wolthers as Head of [...]
DaltonTx appoints Melissa Landon as Chief Commercial Officer to drive commercial growth and strategic partnerships
12/11/2026
Dr Landon brings 20+ years of experience in the application of AI/ ML to drug discovery She joins Dalton Tx to drive adoption of Dalton Tx ’s platform across pharma, biotech and CROs LONDON, Nov. 12, 2026 (GLOBE [...]
Evosep Appoints Scientia Life Technologies as Distributor in India
12/11/2026
Partnership gives India’s proteomics community more direct access to Evosep solutions, local expertise and support BHUBANESWAR, India , Nov. 12, 2026 (GLOBE NEWSWIRE) -- Evosep today announced the appointment of [...]
RAMSAY SANTE obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia
12/11/2026
REGULATORY INFORMATION Paris, November 12, 2026 Ramsay Santé obtains approval from the Australian Securities Exchange for its foreign exempt listing in Australia Ramsay Santé today announces that the Australian [...]
RAMSAY SANTE obtient l'approbation de l'Australian Securities Exchange pour sa cotation en Australie en tant qu'entité étrangère exemptée
12/11/2026
INFORMATION RÉGLEMENTÉE Paris le 12 novembre 2026 Ramsay Santé obtient l’approbation de l’ Australian Securities Exchange pour sa cotation en Australie en tant qu’entité étrangère exemptée Ramsay Santé annonce aujourd’ [...]
Mironid strengthens Board and clinical team to support next phase of growth
12/11/2026
Dr. Omar Khwaja joins the Board as Non-Executive Director Senior leadership team further strengthened with the appointments of Lars Erwig and Kimberly Hoffman Glasgow, Scotland, November 12, 2026 – Mironid, a [...]
Zealand Pharma Announces Financial Results for the First Nine Months of 2026
12/11/2026
Company announcement – No. 56 / 2026 Zealand Pharma Announces Financial Results for the First Nine Months of 2026 Advancing at pace towards Metabolic Frontier 2030: petrelintide in Phase 3, survodutide moving towards [...]
Santhera Signs Distribution Agreement with SteinCares for AGAMREE® (Vamorolone) in 31 countries across Latin America and the Caribbean
12/11/2026
Pratteln, Switzerland, November 12, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces it has signed an exclusive agreement with SteinCares for the distribution of AGAMREE® (vamorolone) for the treatment of Duchenne [...]
Top Outsourcing Medical Billing Services at Remitwright: Denial Management, A/R Recovery, Credentialing, NEMT and Home Care Billing Launch the Company's 2027 Service Line
12/11/2026
The New York medical billing company details the outsourcing medical billing services it is built around, what each one delivers, and how a dedicated billing team changes the result for independent practices. New York [...]
Glass House Brands Announces Change of Auditor
12/11/2026
LONG BEACH, Calif. and TORONTO, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that BDO USA, P.C. ("BDO") resigned as auditor [...]
Juniper Biosciences Builds Clinical and Commercial Leadership Teams with Appointments of Deepak Behera, M.D., as Chief Medical Officer, Javed Mahmood, Ph.D., as Senior Director of Clinical Development, and Robert Sgroi as Chief Commercial Officer
11/11/2026
BEDMINSTER, N.J., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Juniper Biosciences ("Juniper" or "the Company"), a radiopharmaceutical drug development company, today announced the establishment of its clinical team with the [...]
CORRECTION: Milestone Scientific Schedules Third Quarter 2026 Financial Results Conference Call
11/11/2026
In a release issued under the same headline earlier today by Milestone Scientific, Inc., please note that in the first paragraph of the release, the conference call date should have been Friday, November 13, not [...]
Addex Spin-out Neurosterix Closes $105 Million Series B Financing
11/11/2026
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 11, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]
Solana Company Reports Third Quarter 2026 Financial Results
11/11/2026
PHILADELPHIA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury, infrastructure, and services company providing institutional access to [...]
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
11/11/2026
REYKJAVIK, Iceland, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]
Alvotech Announces Financial Results for the Nine Months to September 30, 2026, with a Business Update
11/11/2026
REYKJAVIK, ICELAND (November 11, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]

Pages